| 查看: 99 | 回复: 1 | |||
| 当前主题已经存档。 | |||
[交流]
实在找不到，急用！
|
|||
|
Preclinical safety studies of cefmetazole. Moe JB, Piper RC, Tanase H, Sotani K, Manabe J. Upjohn Company, Kalamazoo, Michigan 49001. In order to assess the safety of cefmetazole, preclinical multiple-dose parenteral studies, varying from one to three months in length, were conducted in Sprague-Dawley rats and beagle dogs. Although the largest doses used were in multiples of several times the weight-adjusted doses intended for humans, cefmetazole was generally well tolerated. The principal adverse effect noted in the adult rats receiving the largest doses (2000 and 2500 mg/kg/day) of cefmetazole was slight elevation of serum alanine aminotransferase. Infant rats injected subcutaneously with 300 mg/kg/day or more of cefmetazole for 35 consecutive days had reversible reductions in testicular weight and maturation of spermatogenesis, but not lasting discernible effect on reproductive function. The most consistent effects of longterm multiple dosing with cefmetazole in dogs consisted of vomiting and retching during dosing and reversible haematological changes (mild regenerative anaemia, positive Coombs' test, clinically-silent thrombocytopenia) in a number of the dogs. These findings supported the interpretation that cefmetazole was acceptably safe for clinical studies in humans. PMID: 2722719 [PubMed - indexed for MEDLINE] 我的E-MAIL：zw1159@163.com |
回复此楼» 猜你喜欢
论文撤稿了
已经有8人回复
-
博士申请
已经有7人回复
-
青B发送上会通知了吗
已经有8人回复
-
化学专业申博
已经有4人回复
-
评审有感
已经有27人回复
-
河北省自然科学基金
已经有9人回复
-
西安交大新媒学院副院长用撤稿论文结题
已经有5人回复
-
某211大学教师把个人教师官方主页改成:我跑了我跑了我跑了!官宣跑路！
已经有5人回复
-
26/27申博自荐
已经有9人回复
-
博士申请
已经有3人回复
|
本帖内容被屏蔽 |
2楼2006-09-25 11:49:34